Profound Medical Corp Stock Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
May. 15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
Sales 2024 * | 15.5M 11.35M | Sales 2025 * | 41.51M 30.39M | Capitalization | 246M 180M |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.29M | Net income 2025 * | -31M -22.7M | EV / Sales 2024 * | 15.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.93 x |
P/E ratio 2024 * |
-6.32
x | P/E ratio 2025 * |
-6.83
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
1st Jan change | Capi. | |
---|---|---|
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.13% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock